Immune cell therapy shows promising results for lymphoma patients

(H. Lee Moffitt Cancer Center& Research Institute) Moffitt Cancer Center physician investigators are working to bring immune cellular therapies to refractory diffuse large B-cell lymphoma patients. Promising results from the phase 1 portion of the ZUMA-1 study, which uses chimeric antigen receptor (CAR) modified T cells to treat b-cell lymphoma patients, were published in the January issue of Molecular Therapy, the official journal of the American Society of Gene and Cell Therapy.
Source: EurekAlert! - Medicine and Health - Category: Global & Universal Source Type: news